Literature DB >> 20623220

Glucosamine-functionalized silver glyconanoparticles: characterization and antibacterial activity.

Murugan Veerapandian1, Suk Kyung Lim, Hyang Mi Nam, Gobianand Kuppannan, Kyusik S Yun.   

Abstract

We report the analytical and in vitro antibacterial activity of glucosamine-functionalized silver glyconanoparticles. Morphological characterization ensured the surface topography and particle size distribution of both silver and glucosamine-silver nanoparticles. Surface plasmon resonance of both types of nanoparticle was determined from UV-visible spectroscopy using four different sample concentrations (10-40 μL). The resulting functionalized glyconanoparticles show maximum absorbance with a red shift of 30 ± 5 nm (390-400 nm) from their initial absorbance (425-430 nm). FT-Raman and (1)H-NMR spectroscopic measurement confirmed the surface functionalization of glucosamine on the silver surface through the carbonyl group of a secondary amide linkage (-NH-CO-), elucidated by the conjugation of N-hydroxysuccinimide (NHS)-terminated silver nanoparticles and the amino group of glucosamine. Antimicrobial experiments with well-characterized silver nanoparticles (AgNPs) and glucosamine-functionalized silver nanoparticles (GlcN-AgNPs) demonstrate that GlcN-AgNPs have similar and enhanced minimum inhibitory concentration (MIC) against eight gram-negative and eight gram-positive bacteria compared with AgNPs. MIC data shows that Klebsiella pneumoniae (ATCC 700603) and Bacillus cereus isolate express high levels of inhibition, with the quantity and magnitude of inhibition being higher in the presence of GlcN-AgNPs.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20623220     DOI: 10.1007/s00216-010-3964-5

Source DB:  PubMed          Journal:  Anal Bioanal Chem        ISSN: 1618-2642            Impact factor:   4.142


  8 in total

1.  Nanoparticles functionalized with ampicillin destroy multiple-antibiotic-resistant isolates of Pseudomonas aeruginosa and Enterobacter aerogenes and methicillin-resistant Staphylococcus aureus.

Authors:  Ashley N Brown; Kathryn Smith; Tova A Samuels; Jiangrui Lu; Sherine O Obare; Maria E Scott
Journal:  Appl Environ Microbiol       Date:  2012-01-27       Impact factor: 4.792

2.  Nanomedicine in the Management of Microbial Infection - Overview and Perspectives.

Authors:  Xi Zhu; Aleksandar F Radovic-Moreno; Jun Wu; Robert Langer; Jinjun Shi
Journal:  Nano Today       Date:  2014-08-01       Impact factor: 20.722

Review 3.  Optical assays based on colloidal inorganic nanoparticles.

Authors:  Amir Ghasemi; Navid Rabiee; Sepideh Ahmadi; Shabnam Hashemzadeh; Farshad Lolasi; Mahnaz Bozorgomid; Alireza Kalbasi; Behzad Nasseri; Amin Shiralizadeh Dezfuli; Amir Reza Aref; Mahdi Karimi; Michael R Hamblin
Journal:  Analyst       Date:  2018-06-20       Impact factor: 4.616

4.  Preparation, Physicochemical Characterization and Anti-fungal Evaluation of Nystatin-Loaded PLGA-Glucosamine Nanoparticles.

Authors:  Ghobad Mohammadi; Amineh Shakeri; Ali Fattahi; Pardis Mohammadi; Ali Mikaeili; Alireza Aliabadi; Khosro Adibkia
Journal:  Pharm Res       Date:  2016-12-07       Impact factor: 4.200

5.  Enhanced of antibacterial activity of antibiotic-functionalized silver nanocomposites with good biocompatibility.

Authors:  Qianqian Guo; Tianyu Lan; Yi Chen; Yini Xu; Jianqing Peng; Ling Tao; Xiangchun Shen
Journal:  J Mater Sci Mater Med       Date:  2019-03-06       Impact factor: 3.896

6.  Glyconanomaterials for Combating Bacterial Infections.

Authors:  Olof Ramström; Mingdi Yan
Journal:  Chemistry       Date:  2015-09-29       Impact factor: 5.236

7.  Functionalized graphene oxide for clinical glucose biosensing in urine and serum samples.

Authors:  Murugan Veerapandian; Yeong-Tai Seo; Hyunkyung Shin; Kyusik Yun; Min-Ho Lee
Journal:  Int J Nanomedicine       Date:  2012-12-18

8.  Ultraviolet light and laser irradiation enhances the antibacterial activity of glucosamine-functionalized gold nanoparticles.

Authors:  Saravanan Govindaraju; Mohankandhasamy Ramasamy; Rengarajan Baskaran; Sang Jung Ahn; Kyusik Yun
Journal:  Int J Nanomedicine       Date:  2015-08-25
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.